2 results
Approved WMOCompleted
1. Overall survival (primary efficacy endpoint)2a. Efficacy: progression-free survival (PFS), overall response rate (ORR = CR + PR), and a clincal benefit rate (CBR) will be evaluated as CR + PR + SD for at least 3 months.2b. Safety: adverse events…
Approved WMORecruiting
• Assessment of clinical, radiographic and subjective outcomes after anatomic or reverse shoulder arthroplasty with SMR stemless prosthesis;• Survival analysis;• Incidence of adverse events and identification of possible risk factors for failure.